Stem Cells and Regenerative Medicine - An Interview with Stephen Minger
As part of our Future Pharma Series, we spoke to Dr. Stephen Minger, Chief Scientist, Research and Applied Markets at Life Sciences, GE Healthcare about the future of regenerative medicine. As he sits on the board of directors for the Centre for Commercialization of Regenerative Medicine, he also discusses how primary research can be translated into commercial success.
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.